# UGI Corp: financial statements, quarterly

UGI · NYSE · CIK 884614 · [Utilities](/sectors/utilities.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ugi.md) · [Financials](/companies/ugi/financials.md) · [Filings](/companies/ugi/filings.md) · [Insiders](/companies/ugi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ugi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,379 d](/filings/0000884614-25-000053.md) | [2,074](/filings/0000884614-25-000008.md) | [2,411](/filings/0000884614-25-000017.md) | [1,352](/filings/0000884614-25-000045.md) | [1,208 d](/filings/0000884614-25-000053.md) | [1,988](/filings/0000884614-26-000011.md) | [2,633](/filings/0000884614-26-000022.md) | [1,360](/filings/0000884614-26-000052.md) | [1,166 d](/filings/0000884614-25-000053.md) | [2,065](/filings/0000884614-26-000011.md) | [2,666](/filings/0000884614-26-000022.md) | [1,299](/filings/0000884614-26-000052.md) |
| Selling, general and administrative | $m | [519 d](/filings/0000884614-25-000053.md) | [530](/filings/0000884614-25-000008.md) | [591](/filings/0000884614-25-000017.md) | [501](/filings/0000884614-25-000045.md) | [510 d](/filings/0000884614-25-000053.md) | [497](/filings/0000884614-26-000011.md) | [546](/filings/0000884614-26-000022.md) | [481](/filings/0000884614-26-000052.md) | [487 d](/filings/0000884614-25-000053.md) | [520](/filings/0000884614-26-000011.md) | [559](/filings/0000884614-26-000022.md) | [491](/filings/0000884614-26-000052.md) |
| Operating income | $m | [237 d](/filings/0000884614-25-000053.md) | [232](/filings/0000884614-25-000008.md) | [717](/filings/0000884614-25-000017.md) | [67.0](/filings/0000884614-25-000045.md) | [(246) d](/filings/0000884614-25-000053.md) | [487](/filings/0000884614-26-000011.md) | [700](/filings/0000884614-26-000022.md) | [(93.0)](/filings/0000884614-26-000052.md) | [13.0 d](/filings/0000884614-25-000053.md) | [454](/filings/0000884614-26-000011.md) | [758](/filings/0000884614-26-000022.md) | [(44.0)](/filings/0000884614-26-000052.md) |
| Interest expense | $m | [98.0 d](/filings/0000884614-23-000104.md) | [100](/filings/0000884614-24-000038.md) | [100](/filings/0000884614-24-000055.md) | [96.0](/filings/0000884614-25-000045.md) | [98.0 d](/filings/0000884614-25-000053.md) | [102](/filings/0000884614-26-000011.md) | [102](/filings/0000884614-26-000022.md) | [101](/filings/0000884614-26-000052.md) | [106 d](/filings/0000884614-25-000053.md) | [111](/filings/0000884614-26-000011.md) | [111](/filings/0000884614-26-000022.md) | [109](/filings/0000884614-26-000052.md) |
| Income tax | $m | [26.0 d](/filings/0000884614-25-000053.md) | [26.0](/filings/0000884614-25-000008.md) | [133](/filings/0000884614-25-000017.md) | [(7.0)](/filings/0000884614-25-000045.md) | [(81.0) d](/filings/0000884614-25-000053.md) | [42.0](/filings/0000884614-26-000011.md) | [115](/filings/0000884614-26-000022.md) | [(65.0)](/filings/0000884614-26-000052.md) | [(74.0) d](/filings/0000884614-25-000053.md) | [54.0](/filings/0000884614-26-000011.md) | [140](/filings/0000884614-26-000022.md) | [(28.0)](/filings/0000884614-26-000052.md) |
| Net income | $m | [131 d](/filings/0000884614-25-000053.md) | [94.0](/filings/0000884614-25-000008.md) | [496](/filings/0000884614-25-000017.md) | [(48.0)](/filings/0000884614-25-000045.md) | [(273) d](/filings/0000884614-25-000053.md) | [375](/filings/0000884614-26-000011.md) | [479](/filings/0000884614-26-000022.md) | [(163)](/filings/0000884614-26-000052.md) | [(13.0) d](/filings/0000884614-25-000053.md) | [297](/filings/0000884614-26-000011.md) | [520](/filings/0000884614-26-000022.md) | [(133)](/filings/0000884614-26-000052.md) |
| Diluted EPS | $ per share | not reported | [0.44](/filings/0000884614-25-000008.md) | [2.30](/filings/0000884614-25-000017.md) | [(0.23)](/filings/0000884614-25-000045.md) | not reported | [1.74](/filings/0000884614-26-000011.md) | [2.19](/filings/0000884614-26-000022.md) | [(0.76)](/filings/0000884614-26-000052.md) | not reported | [1.34](/filings/0000884614-26-000011.md) | [2.33](/filings/0000884614-26-000022.md) | [(0.62)](/filings/0000884614-26-000052.md) |
| Basic EPS | $ per share | not reported | [0.45](/filings/0000884614-25-000008.md) | [2.36](/filings/0000884614-25-000017.md) | [(0.23)](/filings/0000884614-25-000045.md) | not reported | [1.74](/filings/0000884614-26-000011.md) | [2.23](/filings/0000884614-26-000022.md) | [(0.76)](/filings/0000884614-26-000052.md) | not reported | [1.38](/filings/0000884614-26-000011.md) | [2.42](/filings/0000884614-26-000022.md) | [(0.62)](/filings/0000884614-26-000052.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000884614-25-000053.md) | [0.2](/filings/0000884614-25-000008.md) | [0.3](/filings/0000884614-25-000017.md) | [0.2](/filings/0000884614-25-000045.md) | [0.2](/filings/0000884614-25-000053.md) | [0.2](/filings/0000884614-26-000011.md) | [0.4](/filings/0000884614-26-000022.md) | [0.4](/filings/0000884614-26-000052.md) | [0.3](/filings/0000884614-26-000052.md) | [0.3](/filings/0000884614-26-000011.md) | [0.5](/filings/0000884614-26-000022.md) | [0.5](/filings/0000884614-26-000052.md) |
| Current assets | $bn | [2.0](/filings/0000884614-24-000086.md) | [2.3](/filings/0000884614-25-000008.md) | [2.2](/filings/0000884614-25-000017.md) | [1.7](/filings/0000884614-25-000045.md) | [1.7](/filings/0000884614-25-000053.md) | [2.0](/filings/0000884614-26-000011.md) | [2.3](/filings/0000884614-26-000022.md) | [1.8](/filings/0000884614-26-000052.md) | [1.8](/filings/0000884614-26-000052.md) | [2.1](/filings/0000884614-26-000011.md) | [2.5](/filings/0000884614-26-000022.md) | [2.3](/filings/0000884614-26-000052.md) |
| Total assets | $bn | [15.4](/filings/0000884614-25-000053.md) | [15.7](/filings/0000884614-25-000008.md) | [15.6](/filings/0000884614-25-000017.md) | [15.1](/filings/0000884614-25-000045.md) | [15.1](/filings/0000884614-25-000053.md) | [15.4](/filings/0000884614-26-000011.md) | [15.7](/filings/0000884614-26-000022.md) | [15.4](/filings/0000884614-26-000052.md) | [15.5](/filings/0000884614-26-000052.md) | [15.8](/filings/0000884614-26-000011.md) | [16.1](/filings/0000884614-26-000022.md) | [15.6](/filings/0000884614-26-000052.md) |
| Current liabilities | $bn | [2.3](/filings/0000884614-24-000086.md) | [2.3](/filings/0000884614-25-000008.md) | [1.8](/filings/0000884614-25-000017.md) | [1.9](/filings/0000884614-25-000045.md) | [2.1](/filings/0000884614-25-000053.md) | [2.0](/filings/0000884614-26-000011.md) | [1.9](/filings/0000884614-26-000022.md) | [2.6](/filings/0000884614-26-000052.md) | [2.0](/filings/0000884614-26-000052.md) | [2.7](/filings/0000884614-26-000011.md) | [2.5](/filings/0000884614-26-000022.md) | [1.6](/filings/0000884614-26-000052.md) |
| Total liabilities | $bn | [11.0](/filings/0000884614-24-000086.md) | [11.3](/filings/0000884614-25-000008.md) | [10.8](/filings/0000884614-25-000017.md) | [10.4](/filings/0000884614-25-000045.md) | [10.7](/filings/0000884614-25-000053.md) | [10.8](/filings/0000884614-26-000011.md) | [10.7](/filings/0000884614-26-000022.md) | [10.5](/filings/0000884614-26-000052.md) | [10.7](/filings/0000884614-26-000052.md) | [10.8](/filings/0000884614-26-000011.md) | [10.7](/filings/0000884614-26-000022.md) | [10.4](/filings/0000884614-26-000052.md) |
| Long-term debt | $bn | [6.5](/filings/0000884614-24-000086.md) | not reported | not reported | not reported | [6.4](/filings/0000884614-25-000053.md) | not reported | not reported | not reported | [6.5](/filings/0000884614-25-000053.md) | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.1](/filings/0000884614-24-000086.md) | not reported | not reported | not reported | [0.2](/filings/0000884614-25-000053.md) | not reported | not reported | not reported | [0.1](/filings/0000884614-25-000053.md) | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.4](/filings/0000884614-24-000086.md) | [4.4](/filings/0000884614-25-000008.md) | [4.8](/filings/0000884614-25-000017.md) | [4.7](/filings/0000884614-25-000045.md) | [4.3](/filings/0000884614-25-000053.md) | [4.6](/filings/0000884614-26-000011.md) | [5.0](/filings/0000884614-26-000022.md) | [4.9](/filings/0000884614-26-000052.md) | [4.8](/filings/0000884614-26-000052.md) | [5.0](/filings/0000884614-26-000011.md) | [5.4](/filings/0000884614-26-000022.md) | [5.2](/filings/0000884614-26-000052.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [250 d](/filings/0000884614-25-000053.md) | [119](/filings/0000884614-25-000008.md) | [522 d](/filings/0000884614-25-000017.md) | [390 d](/filings/0000884614-25-000045.md) | [151 d](/filings/0000884614-25-000053.md) | [164](/filings/0000884614-26-000011.md) | [684 d](/filings/0000884614-26-000022.md) | [289 d](/filings/0000884614-26-000052.md) | [90.0 d](/filings/0000884614-25-000053.md) | [66.0](/filings/0000884614-26-000011.md) | [664 d](/filings/0000884614-26-000022.md) | [242 d](/filings/0000884614-26-000052.md) |
| Capital expenditure | $m | [304 d](/filings/0000884614-25-000053.md) | [156](/filings/0000884614-25-000008.md) | [169 d](/filings/0000884614-25-000017.md) | [205 d](/filings/0000884614-25-000045.md) | [266 d](/filings/0000884614-25-000053.md) | [211](/filings/0000884614-26-000011.md) | [146 d](/filings/0000884614-26-000022.md) | [222 d](/filings/0000884614-26-000052.md) | [258 d](/filings/0000884614-25-000053.md) | [221](/filings/0000884614-26-000011.md) | [170 d](/filings/0000884614-26-000022.md) | [226 d](/filings/0000884614-26-000052.md) |
| Dividends paid | $m | [78.0 d](/filings/0000884614-25-000053.md) | [79.0](/filings/0000884614-25-000008.md) | [78.0 d](/filings/0000884614-25-000017.md) | [81.0 d](/filings/0000884614-25-000045.md) | [80.0 d](/filings/0000884614-25-000053.md) | [81.0](/filings/0000884614-26-000011.md) | [80.0 d](/filings/0000884614-26-000022.md) | [80.0 d](/filings/0000884614-26-000052.md) | [81.0 d](/filings/0000884614-25-000053.md) | [81.0](/filings/0000884614-26-000011.md) | [80.0 d](/filings/0000884614-26-000022.md) | [80.0 d](/filings/0000884614-26-000052.md) |
| Share repurchases | $m | [0.0 d](/filings/0000884614-25-000053.md) | [0.0](/filings/0000884614-24-000038.md) | [0.0 d](/filings/0000884614-25-000017.md) | [0.0 d](/filings/0000884614-25-000045.md) | [0.0 d](/filings/0000884614-25-000053.md) | [0.0](/filings/0000884614-26-000011.md) | [17.0 d](/filings/0000884614-26-000022.md) | [0.0 d](/filings/0000884614-26-000052.md) | [16.0 d](/filings/0000884614-25-000053.md) | [12.0](/filings/0000884614-26-000011.md) | [11.0 d](/filings/0000884614-26-000022.md) | [0.0 d](/filings/0000884614-26-000052.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [210](/filings/0000884614-24-000038.md) | [216](/filings/0000884614-24-000055.md) | [210](/filings/0000884614-24-000072.md) | [216](/filings/0000884614-25-000008.md) | [215](/filings/0000884614-25-000017.md) | [211](/filings/0000884614-25-000045.md) | [216](/filings/0000884614-26-000011.md) | [219](/filings/0000884614-26-000022.md) | [215](/filings/0000884614-26-000052.md) | [221](/filings/0000884614-26-000011.md) | [223](/filings/0000884614-26-000022.md) | [215](/filings/0000884614-26-000052.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 214,494,967 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000884614-26-000052.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.